Cargando…

Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. A growing number of studies have shown that competitive endogenous RNA (ceRNA) regulatory networks might play important roles during HCC process. The present study aimed to identify a regulatory axis of the ceRNA network associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shangshang, Zhang, Jinyan, Guo, Guoqing, Zhang, Li, Dai, Jing, Gao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049542/
https://www.ncbi.nlm.nih.gov/pubmed/35482720
http://dx.doi.org/10.1371/journal.pone.0267117
_version_ 1784696161282555904
author Hu, Shangshang
Zhang, Jinyan
Guo, Guoqing
Zhang, Li
Dai, Jing
Gao, Yu
author_facet Hu, Shangshang
Zhang, Jinyan
Guo, Guoqing
Zhang, Li
Dai, Jing
Gao, Yu
author_sort Hu, Shangshang
collection PubMed
description Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. A growing number of studies have shown that competitive endogenous RNA (ceRNA) regulatory networks might play important roles during HCC process. The present study aimed to identify a regulatory axis of the ceRNA network associated with the development of HCC. The roles of SNX16 and PAPOLG in HCC were comprehensively analyzed using bioinformatics tools. Subsequently, the “mRNA-miRNA-lncRNA” model was then used to predict the upstream miRNAs and lncRNAs of SNX16 and PAPOLG using the miRNet database, and the miRNAs with low expression and good prognosis in HCC and the lncRNAs with high expression and poor prognosis in HCC were screened by differential expression and survival analysis. Finally, the risk-prognosis models of ceRNA network axes were constructed by univariate and multifactorial Cox proportional risk analysis, and the immune correlations of ceRNA network axes were analyzed using the TIMER and GEPIA database. In this study, the relevant ceRNA network axis GSEC/miR-101-3p/SNX16/PAPOLG with HCC prognosis was constructed, in which GSEC, SNX16, and PAPOLG were highly expressed in HCC with poor prognosis, while miR-101-3p was lowly expressed in HCC with good prognosis. The risk-prognosis model predicted AUC of 0.691, 0.623, and 0.626 for patient survival at 1, 3, and 5 years, respectively. Immuno-infiltration analysis suggested that the GSEC/miR-101-3p/SNX16/PAPOLG axis might affect macrophage polarization. The GSEC/miR-101-3p/SNX16/PAPOLG axis of the ceRNA network axis might be an important factor associated with HCC prognosis and immune infiltration.
format Online
Article
Text
id pubmed-9049542
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90495422022-04-29 Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma Hu, Shangshang Zhang, Jinyan Guo, Guoqing Zhang, Li Dai, Jing Gao, Yu PLoS One Research Article Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. A growing number of studies have shown that competitive endogenous RNA (ceRNA) regulatory networks might play important roles during HCC process. The present study aimed to identify a regulatory axis of the ceRNA network associated with the development of HCC. The roles of SNX16 and PAPOLG in HCC were comprehensively analyzed using bioinformatics tools. Subsequently, the “mRNA-miRNA-lncRNA” model was then used to predict the upstream miRNAs and lncRNAs of SNX16 and PAPOLG using the miRNet database, and the miRNAs with low expression and good prognosis in HCC and the lncRNAs with high expression and poor prognosis in HCC were screened by differential expression and survival analysis. Finally, the risk-prognosis models of ceRNA network axes were constructed by univariate and multifactorial Cox proportional risk analysis, and the immune correlations of ceRNA network axes were analyzed using the TIMER and GEPIA database. In this study, the relevant ceRNA network axis GSEC/miR-101-3p/SNX16/PAPOLG with HCC prognosis was constructed, in which GSEC, SNX16, and PAPOLG were highly expressed in HCC with poor prognosis, while miR-101-3p was lowly expressed in HCC with good prognosis. The risk-prognosis model predicted AUC of 0.691, 0.623, and 0.626 for patient survival at 1, 3, and 5 years, respectively. Immuno-infiltration analysis suggested that the GSEC/miR-101-3p/SNX16/PAPOLG axis might affect macrophage polarization. The GSEC/miR-101-3p/SNX16/PAPOLG axis of the ceRNA network axis might be an important factor associated with HCC prognosis and immune infiltration. Public Library of Science 2022-04-28 /pmc/articles/PMC9049542/ /pubmed/35482720 http://dx.doi.org/10.1371/journal.pone.0267117 Text en © 2022 Hu et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hu, Shangshang
Zhang, Jinyan
Guo, Guoqing
Zhang, Li
Dai, Jing
Gao, Yu
Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title_full Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title_fullStr Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title_full_unstemmed Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title_short Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
title_sort comprehensive analysis of gsec/mir-101-3p/snx16/papolg axis in hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049542/
https://www.ncbi.nlm.nih.gov/pubmed/35482720
http://dx.doi.org/10.1371/journal.pone.0267117
work_keys_str_mv AT hushangshang comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma
AT zhangjinyan comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma
AT guoguoqing comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma
AT zhangli comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma
AT daijing comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma
AT gaoyu comprehensiveanalysisofgsecmir1013psnx16papolgaxisinhepatocellularcarcinoma